Yoga for Symptoms of Nerve Damage Caused by Chemotherapy

Inclusion Criteria:

English-speaking
Age >/= 18 years old
Survivors with a primary diagnosis of stage I-III breast, ovarian uterine, or endometrial cancer
Moderate to severe chemotherapy induced peripheral neuropathy, defined by symptoms such as numbness, tingling, or pain ratings of 4 or greater on a 0-10 numeric rating scale
Have completed neurotoxic chemotherapy, i.e. taxanes (paclitaxel, docetaxel) and platinum (carboplatin) at least 3 months prior to enrollment
If taking anti-neuropathy medications, they are on a stable regiment (no change in 3 months)
ECOG performance status 0-2

Exclusion Criteria:

Participants with metastatic disease
Participants who are currently receiving physical therapy or practicing yoga for any reason

Control Group - Inclusion/Exclusion Criteria

Inclusion Criteria:

English speaking
Age >/= 18 years old
Survivors with a primary diagnosis of Stage I-III breast, ovarian, uterine, or endometrial cancer
CIPN symptoms such as numbness, tingling, or pain ratings < 2 on a 0-10 NRS scale
Have completed neurotoxic chemotherapy, i.e. taxanes (paclitaxel, docetaxel) and platinum (carboplatin) at least 3 months prior to enrollment
ECOG performance status 0-2

Exclusion Criteria:

Patients with metastatic disease
Patients taking anti-neuropathy medication
Patients who are currently receiving physical therapy or practicing yoga for any reason